Page last updated: 2024-08-21

alpha-aminopyridine and Esophageal Squamous Cell Carcinoma

alpha-aminopyridine has been researched along with Esophageal Squamous Cell Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Doi, T; Hara, H; Kato, K; Kojima, T; Muro, K; Nishina, T; Nomura, S; Ohtsu, A; Sato, A; Takahashi, S; Wakabayashi, M	1
Chen, K; Cheng, G; Futreal, A; Han, M; Huang, M; Jin, J; Li, B; Li, F; Li, JY; Lin, Y; Mao, W; Su, D; Wang, J; Wang, K; Wu, J; Xie, Z; Xiong, L; Ying, L; Zhang, D; Zhang, F; Zhang, J	1
Chen, P; Guo, Y; Hu, T; Hu, X; Li, J; Li, M; Li, P; Sha, B; Shi, J; Sun, Y; Wang, L; Wang, Y; Xu, Y; Zhu, M	1

Trials

1 trial(s) available for alpha-aminopyridine and Esophageal Squamous Cell Carcinoma

Article	Year
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303). Esophagus : official journal of the Japan Esophageal Society, 2022, Volume: 19, Issue:4 Topics: Aminopyridines; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Morpholines; Phosphatidylinositol 3-Kinases	2022

Other Studies

2 other study(ies) available for alpha-aminopyridine and Esophageal Squamous Cell Carcinoma

Article	Year
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma. Nature communications, 2019, 11-07, Volume: 10, Issue:1 Topics: Adult; Aged; Aminopyridines; Biomarkers, Tumor; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Purines; Pyridines; Xenograft Model Antitumor Assays	2019
Inhibition of deubiquitination by PR-619 induces apoptosis and autophagy via ubi-protein aggregation-activated ER stress in oesophageal squamous cell carcinoma. Cell proliferation, 2021, Volume: 54, Issue:1 Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Protein Aggregates; Thiocyanates; Tumor Cells, Cultured; Ubiquitin; Ubiquitination	2021

Article

Year

Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.

Nature communications, 2019, 11-07, Volume: 10, Issue:1

Topics: Adult; Aged; Aminopyridines; Biomarkers, Tumor; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Male; Middle Aged; Piperazines; Prognosis; Protein Kinase Inhibitors; Purines; Pyridines; Xenograft Model Antitumor Assays

2019

Inhibition of deubiquitination by PR-619 induces apoptosis and autophagy via ubi-protein aggregation-activated ER stress in oesophageal squamous cell carcinoma.

Cell proliferation, 2021, Volume: 54, Issue:1

Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Protein Aggregates; Thiocyanates; Tumor Cells, Cultured; Ubiquitin; Ubiquitination

2021